TY - JOUR
T1 - In search of new therapeutic targets and strategies for heart failure
T2 - Recent advances in basic science
AU - Shah, Ajay M.
AU - Mann, Douglas L.
N1 - Funding Information:
Research in the authors' laboratories is supported by: the British Heart Foundation, a Leducq Fondation Transatlantic Network of Excellence, and National Institute for Health Research comprehensive Biomedical Research Centre funding (AMS); and by the National Institute of Health (DLM [ RO1 HL58081, HL73017, HL089543 ]).
PY - 2011
Y1 - 2011
N2 - Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte - eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.
AB - Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte - eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.
UR - http://www.scopus.com/inward/record.url?scp=80051968584&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(11)60894-5
DO - 10.1016/S0140-6736(11)60894-5
M3 - Review article
C2 - 21856484
AN - SCOPUS:80051968584
SN - 0140-6736
VL - 378
SP - 704
EP - 712
JO - The Lancet
JF - The Lancet
IS - 9792
ER -